Show notes at pharmacyjoe.com/episode378.
In this episode I’ll:
1. Discuss an article about the safety of high-dose IV labetalol
2. Answer the drug information question “Why is oral ketorolac restricted to patients that are continuing a 5-day course that started as parenteral therapy?”
Leave a Reply